drugset / Trial / NCT02071316

The Use of Hexacapron in Upper Gastrointestinal Bleeding

NCT02071316

Unknown 300 enrolled Shaare Zedek Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to conduct a randomized control trial, double-blind study to compare Hexacapron with standard of care treatment to standard of care alone to evaluate the efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of rebleeding and mortality in patient with upper gastrointestinal bleeding.

Timeline

Start
2014-04
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hexacapron Unknown 6 g Intravenous
Comparator Esomeprazole Small molecule 8 mg Intravenous

Indications

No indication recorded.